文献
J-GLOBAL ID:201802290337021787
整理番号:18A0526410
癌治療のための生物が利用可能なCDK4/6阻害剤としてtetrahydronaphthyridine誘導体の設計,合成および生物学的評価【Powered by NICT】
Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy
著者 (15件):
Zha Chuantao
(Shanghai HaiHe Pharmaceutical, Co. Ltd, No. 421 Newton Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Deng Wenjia
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Deng Wenjia
(University of Chinese Academy of Sciences, Beijing 100049, China)
,
Fu Yan
(Shanghai HaiHe Pharmaceutical, Co. Ltd, No. 421 Newton Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Tang Shuai
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Lan Xiaojing
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Ye Yan
(Shanghai HaiHe Pharmaceutical, Co. Ltd, No. 421 Newton Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Su Yi
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Jiang Lei
(Shanghai HaiHe Pharmaceutical, Co. Ltd, No. 421 Newton Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Chen Yi
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Huang Ying
(Shanghai HaiHe Pharmaceutical, Co. Ltd, No. 421 Newton Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Ding Jian
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Geng Meiyu
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Huang Min
(Division of Antitumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, No. 555 Zuchongzhi Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
,
Wan Huixin
(Shanghai HaiHe Pharmaceutical, Co. Ltd, No. 421 Newton Road, Zhangjiang Hi-tech Park, Pudong New Area, Shanghai 201203, China)
資料名:
European Journal of Medicinal Chemistry
(European Journal of Medicinal Chemistry)
巻:
148
ページ:
140-153
発行年:
2018年
JST資料番号:
E0845A
ISSN:
0223-5234
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)